{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:56:38Z","timestamp":1776056198463,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42665-y","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:15:45Z","timestamp":1772680545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Propofol regulates METTL3-mediated PARP-1 m6A modification to promote Parthanatos to improve NSCLC chemotherapy resistance"],"prefix":"10.1038","volume":"16","author":[{"given":"Quan","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kepeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"42665_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.lungcan.2020.01.010","volume":"141","author":"JR Gosney","year":"2020","unstructured":"Gosney, J. R., Boothman, A. M., Ratcliffe, M. & Kerr, K. M. Cytology for PD-L1 testing: a systematic review. Lung Cancer. 141, 101\u2013106 (2020).","journal-title":"Lung Cancer"},{"key":"42665_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"42665_CR3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu, H., Cao, S. & Xu, R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun. (Lond.) 41, 1037\u20131048 (2021).","journal-title":"Cancer Commun. (Lond.)"},{"key":"42665_CR4","doi-asserted-by":"crossref","unstructured":"Siegel, M. K. D. et al. Colorectal cancer statistics, 2020. CA Cancer J. Clin. 70, 145\u2013164 (2020).","DOI":"10.3322\/caac.21601"},{"key":"42665_CR5","first-page":"3415","volume":"15","author":"B Zou","year":"2018","unstructured":"Zou, B., Zhou, X. L., Lai, S. Q. & Liu, J. C. Notch signaling and non-small cell lung cancer. Oncol. Lett. 15, 3415\u20133421 (2018).","journal-title":"Oncol. Lett."},{"key":"42665_CR6","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Effects and mechanism of microRNA\u2013218 against lung cancer. Mol. Med. Rep. 23, 8596 (2021).","DOI":"10.3892\/mmr.2020.11666"},{"key":"42665_CR7","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1213\/ANE.0000000000004778","volume":"131","author":"X Zheng","year":"2020","unstructured":"Zheng, X. et al. Propofol affects non-small-cell lung cancer cell biology by regulating the miR-21\/PTEN\/AKT pathway in vitro and in vivo. Anesth. Analg. 131, 1270\u20131280 (2020).","journal-title":"Anesth. Analg."},{"key":"42665_CR8","doi-asserted-by":"publisher","first-page":"20230799","DOI":"10.1515\/med-2023-0799","volume":"18","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy. Open. Med. (Warsaw Poland). 18, 20230799 (2023).","journal-title":"Open. Med. (Warsaw Poland)"},{"key":"42665_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12885-022-09848-y","volume":"22","author":"Q Ling","year":"2022","unstructured":"Ling, Q., Wu, S., Liao, X., Liu, C. & Chen, Y. Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p\/RAP1-NF-\u03baB axis. BMC cancer. 22, 765 (2022).","journal-title":"BMC cancer"},{"key":"42665_CR10","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science 354, 7485 (2016).","DOI":"10.1126\/science.aad6872"},{"key":"42665_CR11","doi-asserted-by":"crossref","unstructured":"Huang, P. et al. Molecular mechanisms of Parthanatos and its role in diverse diseases. Int. J. Mol. Sci. 23, 2563 (2022).","DOI":"10.3390\/ijms23137292"},{"key":"42665_CR12","doi-asserted-by":"publisher","first-page":"105299","DOI":"10.1016\/j.phrs.2020.105299","volume":"163","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Parthanatos and its associated components: promising therapeutic targets for cancer. Pharmacol. Res. 163, 105299 (2021).","journal-title":"Pharmacol. Res."},{"key":"42665_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12964-022-00897-1","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Inhibition of AKT induces p53\/SIRT6\/PARP1-dependent parthanatos to suppress tumor growth. Cell. Commun. Signal. 20, 93 (2022).","journal-title":"Cell. Commun. Signal."},{"key":"42665_CR14","doi-asserted-by":"crossref","unstructured":"Ribeiro, D. L. et al. The antitumoral\/antimetastatic action of the flavonoid brachydin A in metastatic prostate tumor spheroids in vitro is mediated by (Parthanatos) PARP-related cell death. Pharmaceutics 14, 2563  (2022).","DOI":"10.3390\/pharmaceutics14050963"},{"key":"42665_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12885-022-09848-y","volume":"22","author":"Q Ling","year":"2022","unstructured":"Ling, Q., Wu, S., Liao, X., Liu, C. & Chen, Y. Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p\/RAP1-NF-kappaB axis. BMC Cancer. 22, 765 (2022).","journal-title":"BMC Cancer"},{"key":"42665_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41419-018-0996-9","volume":"9","author":"H Zhong","year":"2018","unstructured":"Zhong, H. et al. Propofol inhibits parthanatos via ROS-ER-calcium-mitochondria signal pathway in vivo and vitro. Cell Death Dis. 9, 932 (2018).","journal-title":"Cell Death Dis."},{"key":"42665_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13045-021-01173-4","volume":"14","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. m(6)A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer. J. Hematol. Oncol. 14, 190 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"42665_CR18","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1158\/1078-0432.CCR-23-2357","volume":"30","author":"S Guan","year":"2024","unstructured":"Guan, S. et al. Germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression in patients with non-small cell lung cancer. Clin. Cancer Res. 30, 1382\u20131396 (2024).","journal-title":"Clin. Cancer Res."},{"key":"42665_CR19","doi-asserted-by":"publisher","first-page":"981567","DOI":"10.3389\/fgene.2022.981567","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z., Li, Y., Shen, L., Shen, L. & Li, N. Molecular characterization, clinical relevance and immune feature of m7G regulator genes across 33 cancer types. Front. Genet. 13, 981567 (2022).","journal-title":"Front. Genet."},{"key":"42665_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41419-020-02828-9","volume":"11","author":"Y Lu","year":"2020","unstructured":"Lu, Y. et al. Propofol-induced MiR-20b expression initiates endogenous cellular signal changes mitigating hypoxia\/re-oxygenation-induced endothelial autophagy in vitro. Cell. Death Dis. 11, 681 (2020).","journal-title":"Cell. Death Dis."},{"key":"42665_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00018-022-04129-0","volume":"79","author":"H Li","year":"2022","unstructured":"Li, H. et al. METTL3 promotes oxaliplatin resistance of gastric cancer CD133\u2009+\u2009stem cells by promoting PARP1 mRNA stability. Cell. Mol. Life Sci. 79, 135 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"42665_CR22","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.18632\/aging.202386","volume":"13","author":"D Li","year":"2021","unstructured":"Li, D. et al. Oxaliplatin induces the PARP1-mediated parthanatos in oral squamous cell carcinoma by increasing production of ROS. Aging 13, 4242\u20134257 (2021).","journal-title":"Aging"},{"key":"42665_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10238-024-01538-2","volume":"25","author":"H Liu","year":"2024","unstructured":"Liu, H. & Wang, P. CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance. Clin. Exp. Med. 25, 21 (2024).","journal-title":"Clin. Exp. Med."},{"key":"42665_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-1001","volume":"5","author":"Z Chen","year":"2024","unstructured":"Chen, Z. & Er Saw, P. Integration in biomedical science 2024: emerging trends in the post-pandemic era.  BIO Integr. 5, 1\u20132 (2024).","journal-title":"BIO Integr."},{"key":"42665_CR25","doi-asserted-by":"publisher","first-page":"107558","DOI":"10.1016\/j.pharmthera.2020.107558","volume":"212","author":"H Liu","year":"2020","unstructured":"Liu, H., Dilger, J. P. & Lin, J. Effects of local anesthetics on cancer cells. Pharmacol. Ther. 212, 107558 (2020).","journal-title":"Pharmacol. Ther."},{"key":"42665_CR26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s12885-018-4576-2","volume":"18","author":"R Li","year":"2018","unstructured":"Li, R. et al. Effects of local anesthetics on breast cancer cell viability and migration. BMC Cancer. 18, 666 (2018).","journal-title":"BMC Cancer"},{"key":"42665_CR27","doi-asserted-by":"crossref","unstructured":"Liu, H., Dilger, J. P. & Lin, J. Lidocaine suppresses viability and migration of human breast cancer cells: TRPM7 as a target for some breast cancer cell lines. Cancers (Basel) 13, 2563 (2021).","DOI":"10.3390\/cancers13020234"},{"key":"42665_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12871-018-0543-3","volume":"18","author":"R Li","year":"2018","unstructured":"Li, R., Liu, H., Dilger, J. P. & Lin, J. Effect of propofol on breast cancer cell, the immune system, and patient outcome. BMC Anesthesiol. 18, 77 (2018).","journal-title":"BMC Anesthesiol"},{"key":"42665_CR29","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1021\/acs.jmedchem.3c00397","volume":"66","author":"D Chen","year":"2023","unstructured":"Chen, D. et al. Allosteric inhibitors of macrophage migration inhibitory factor (MIF) interfere with apoptosis-inducing factor (AIF) co-localization to prevent Parthanatos. J. Med. Chem. 66, 8767\u20138781 (2023).","journal-title":"J. Med. Chem."},{"key":"42665_CR30","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41416-024-02618-6","volume":"130","author":"M Medrano","year":"2024","unstructured":"Medrano, M. et al. Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions. Br. J. Cancer. 130, 1529\u20131541 (2024).","journal-title":"Br. J. Cancer"},{"key":"42665_CR31","doi-asserted-by":"crossref","unstructured":"Li, R. et al. The potential effect of general anesthetics in cancer surgery: meta-analysis of postoperative metastasis and inflammatory cytokines. Cancers (Basel) 15, 14523 (2023).","DOI":"10.3390\/cancers15102759"},{"key":"42665_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1574892817666220119121204","volume":"17","author":"Z Jin","year":"2022","unstructured":"Jin, Z. et al. Potential therapeutic application of local anesthetics in cancer treatment. Recent. Pat. Anticancer Drug Discov. 17, 326\u2013342 (2022).","journal-title":"Recent. Pat. Anticancer Drug Discov."},{"key":"42665_CR33","doi-asserted-by":"publisher","first-page":"166941","DOI":"10.1016\/j.bbadis.2023.166941","volume":"1870","author":"ZR Kang","year":"2024","unstructured":"Kang, Z. R. et al. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 166941 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"42665_CR34","doi-asserted-by":"publisher","first-page":"167250","DOI":"10.1016\/j.bbadis.2024.167250","volume":"1870","author":"SJ Lee","year":"2024","unstructured":"Lee, S. J. et al. hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 167250 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"42665_CR35","doi-asserted-by":"publisher","first-page":"e210723218988","DOI":"10.2174\/1874467217666230721123554","volume":"17","author":"XJ Qian","year":"2024","unstructured":"Qian, X. J., Wang, J. W., Liu, J. B. & Yu, X. The mediating role of miR-451\/ETV4\/MMP13 signaling axis on epithelialmesenchymal transition in promoting non-small cell lung cancer progression. Curr. Mol. Pharmacol. 17, e210723218988 (2024).","journal-title":"Curr. Mol. Pharmacol."},{"key":"42665_CR36","doi-asserted-by":"crossref","unstructured":"Xie, M., Liu, B., Chen, Z., Cao, T. & Zhang, X. Transcriptomic signatures in TP53 positive and negative tumor samples in NSCLC. Curr. Gene Ther.  (2025).","DOI":"10.2174\/0115665232357300250805021330"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42665-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42665-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42665-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:39:20Z","timestamp":1776055160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42665-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42665"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42665-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Our study has been approved by laboratory animal care and ethics committee of Guangdong Laidi Biomedical Research lnstitute Co, LTD (Approval No. 2024027-3).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"12110"}}